Trials / Completed
CompletedNCT07239765
A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD
An Open-label Study to Evaluate the Safety, Efficacy, and Population Pharmacokinetic Characteristics of Amphotericin B Cholesteryl Sulfate Complex Injection in Patients With Invasive Mold Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Amphotericin B Cholesteryl Sulfate Complex (ABCD) is a generic drug of amphotericin B colloidal dispersion. This study aimed to explore the safety and efficacy of ABCD in patients with invasive mold disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABCD | intravenous infusion |
Timeline
- Start date
- 2021-07-09
- Primary completion
- 2024-04-08
- Completion
- 2024-04-29
- First posted
- 2025-11-20
- Last updated
- 2025-11-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07239765. Inclusion in this directory is not an endorsement.